|Bid||16.60 x 1100|
|Ask||16.99 x 1000|
|Day's range||16.53 - 17.29|
|52-week range||12.52 - 22.40|
|Beta (5Y monthly)||1.37|
|PE ratio (TTM)||N/A|
|Earnings date||03 Aug 2021 - 09 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||34.00|
Heron Therapeutics (HRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investors need to pay close attention to Heron Therapeutics (HRTX) stock based on the movements in the options market lately.
Heron Therapeutics (HRTX) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.